Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
Tzeng A, Diaz-Montero CM, Rayman PA, Kim JS, Pavicic PG Jr, Finke JH, Barata PC, Lamenza M, Devonshire S, Schach K, Emamekhoo H, Ernstoff MS, Hoimes CJ, Rini BI, Garcia JA, Gilligan TD, Ornstein MC, Grivas P.
Tzeng A, et al. Among authors: rayman pa.
Target Oncol. 2018 Oct;13(5):599-609. doi: 10.1007/s11523-018-0595-9.
Target Oncol. 2018.
PMID: 30267200